Last update:

HIV & AIDS news

Medications

Gilead licenses HIV-prevention drug to generic drugmakers

US pharmaceutical giant Gilead said Wednesday it had signed licensing deals with six generic drugmakers to produce and sell its HIV prevention medicine in lower-income countries.

HIV & AIDS

'Undetectable' HIV patients could hold key to treatments

A rare group of HIV-positive people who maintain undetectable levels of the virus in their blood without medication could hold the key to new therapies for others living with the disease, says a leading genome expert.

HIV & AIDS

S.Africa's HIV research power couple says fight goes on

Through decades of pioneering work on fighting the spread of infectious diseases such as HIV, South African public health power couple Quarraisha and Salim Abdool Karim are credited with saving thousands of lives.

HIV & AIDS

How HIV/AIDS got its name

The Centers for Disease Control and Prevention first used the term "AIDS" on Sept. 24, 1982, more than a year after the first cases appeared in medical records. Those early years of the crisis were marked by a great deal ...

HIV & AIDS

Childhood HIV vaccination strategy shows promise in study

Research at Weill Cornell Medicine suggests that childhood immunization against HIV could one day provide protection before the risk of contracting this potentially fatal infection dramatically increases in adolescence.

HIV & AIDS

Ugandan women's autonomy key to safer sex, researchers say

Ugandan women's ability to negotiate the conditions and timing of sex, such as refusing sex and asking for condom use with their partners, is key to preventing several reproductive health outcomes, say experts from the Brown ...

HIV & AIDS

Blood T cells are resistant to HIV's primary death pathway

Scientists from the Gladstone Institutes have discovered that blood-derived T cells are resistant to the chief cause of cell death in HIV infection. Instead, it is T cells in the lymphoid tissues that are most susceptible ...

HIV & AIDS

Vaginal microbes influence whether mucus can trap HIV virus

HIV particles are effectively trapped by the cervicovaginal mucus from women who harbor a particular vaginal bacteria species, Lactobacillus crispatus. The findings, published this week in mBio, an online open-access journal ...

HIV & AIDS

Videos reveal how HIV spreads in real time

How retroviruses like HIV spread in their hosts had been unknown—until a Yale team devised a way to watch it actually happen in a living organism. The elaborate and sometimes surprising steps the virus takes to reach and ...

HIV & AIDS

Drug used to treat HIV linked to lower bone mass in newborns

Infants exposed in the womb to a drug used to treat HIV and reduce the transmission of HIV from mother to child, may have lower bone mineral content than those exposed to other anti-HIV drugs, according to a National Institutes ...

HIV & AIDS

Researchers find proteins that shut down HIV-1

A pair of studies by researchers at the University of Massachusetts Medical School, the University of Trento in Italy, and the University of Geneva in Switzerland, point to a promising new anti-retroviral strategy for combating ...

HIV & AIDS

Future of HIV cure research points to combination approach

The next five years of HIV research should shift gears from the classic single-therapy development model to moving directly from in vitro studies to combination therapy trials, authors argue in a new paper published online ...

HIV & AIDS

Romidepsin can reverse HIV latency in patients on long-term ART

A cure for HIV requires the eradication of latent (i.e., dormant and therefore hidden) virus from reservoirs in immune cells throughout the body. HIV latency depends on the activity of proteins from the human host called ...